Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PHE885 |
Trade Name | |
Synonyms | PHE-885|PHE 885|Autologous Anti-BCMA CAR T-cells PHE885 |
Drug Descriptions |
PHE885 are T-lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting BCMA (TNFRSF17), which may lead to antitumor activity (Blood (2021) 138 (Supplement 1): 3864). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C174124 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
PHE885 | PHE885 | 0 | 2 |